# ING Groep NV: financial statements, quarterly

ING · NYSE · CIK 1039765 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ing.md) · [Financials](/companies/ing/financials.md) · [Filings](/companies/ing/filings.md) · [Insiders](/companies/ing/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ing/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [17.1](/filings/0001193125-18-101492.md) | [20.4](/filings/0001562762-19-000074.md) | [16.2](/filings/0001562762-20-000105.md) | [19.0](/filings/0001562762-21-000116.md) | [47.5](/filings/0001562762-22-000122.md) | [54.0](/filings/0001628280-23-007425.md) | [112](/filings/0001628280-24-009782.md) | [108](/filings/0001628280-25-010764.md) | [95.4](/filings/0001628280-26-011979.md) | [93.0](/filings/0001628280-26-011979.md) | [69.1](/filings/0001628280-26-011979.md) | [54.1](/filings/0001628280-26-011979.md) |
| Total assets | $bn | not reported | [1,002](/filings/0001193125-18-101492.md) | [842](/filings/0001562762-19-000074.md) | [844](/filings/0001562762-20-000105.md) | [885](/filings/0001562762-21-000116.md) | [889](/filings/0001562762-22-000122.md) | [934](/filings/0001628280-23-007425.md) | [949](/filings/0001628280-24-009782.md) | [977](/filings/0001628280-25-010764.md) | [980](/filings/0001628280-26-011979.md) | [1,024](/filings/0001628280-26-011979.md) | [1,060](/filings/0001628280-26-011979.md) |
| Total liabilities | $bn | not reported | not reported | [794](/filings/0001193125-18-101492.md) | [795](/filings/0001562762-19-000074.md) | [835](/filings/0001562762-20-000105.md) | [837](/filings/0001562762-21-000116.md) | [881](/filings/0001562762-22-000122.md) | [896](/filings/0001628280-23-007425.md) | [920](/filings/0001628280-24-009782.md) | [925](/filings/0001628280-25-010764.md) | [970](/filings/0001628280-26-011979.md) | [1,005](/filings/0001628280-26-011979.md) |
| Shareholders' equity | $bn | [55.6](/filings/0001193125-18-101492.md) | [45.0](/filings/0001193125-18-101492.md) | [47.3](/filings/0001562762-19-000074.md) | [48.4](/filings/0001562762-20-000105.md) | [49.0](/filings/0001562762-21-000116.md) | [51.0](/filings/0001562762-22-000122.md) | [51.6](/filings/0001628280-23-007425.md) | [52.1](/filings/0001628280-24-009782.md) | [56.5](/filings/0001628280-25-010764.md) | [54.7](/filings/0001628280-26-011979.md) | [52.7](/filings/0001628280-26-011979.md) | [54.1](/filings/0001628280-26-011979.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 2,902,437,688 at 2025-12-31, from the cover of the [20-F filed 2026-02-26](/filings/0001628280-26-011979.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.